Today on The Mary Jane Society, we're joined by Shane Johnson, a Stanford-trained medical doctor and accomplished biotech entrepreneur. Shane is the co-founder of BayMedica, a pioneering manufacturer of rare and minor cannabinoid ingredients known for their exceptional purity, consistency, and scalability traits critical to the future of pharmaceutical-grade cannabinoid products.

BayMedica was acquired by InMed Pharmaceuticals, a NASDAQ-listed, clinical-stage pharmaceutical company based in Canada. InMed is developing a robust pipeline of proprietary small molecule drug candidates that target the CB1 and CB2 receptors of the endocannabinoid system. Their current research programs focus on therapeutic treatments for Alzheimer's disease, as well as ocular and dermatological conditions.

Dive into Shane's insights on cannabinoid drug development, the regulatory landscape, and the future of pharmaceutical innovation in cannabis.

https://www.linkedin.com/in/shanejohnson3

https://www.baymedica.com

https://www.inmedpharma.com

The Mary Jane Society is produced and hosted by Pam Chmiel, a journalist, freelance writer, and marketing and PR specialist in the cannabis industry. Get in touch to discuss your business strategy or explore working together at pam@TheMaryJaneSociety.com.

LinkedIn Twitter Instagram

Please like the show to help us reach more listeners🙏🏻

The Cannabis Media Council was founded to build bridges between the cannabis industry and mainstream media, elevate advertising standards, and help shift public perception through strategic public service announcements. Acting as a think tank of forward-thinking industry leaders, the Council believes in collaboration over competition—sharing knowledge and resources to make sure that all boats rise.

Today, I’m joined by co-founder Amy Deneson to explore the mission behind the Cannabis Media Council, its operations, and the impact it wants to make across media, marketing, and culture.

https://www.cannabismediacouncil.com/

https://www.linkedin.com/in/amydeneson/

The Mary Jane Society is produced and hosted by Pam Chmiel, a journalist, freelance writer, and marketing and PR specialist in the cannabis industry. Get in touch to discuss your business strategy or explore working together at pam@TheMaryJaneSociety.com.

LinkedIn Twitter Instagram

Please like the show to help us reach more listeners🙏🏻

Today, we will learn about a potentially groundbreaking digital platform called The Cancer Playbook that could accelerate cannabis medicine for cancer treatment and redefine how patients, doctors, and researchers approach cancer care.

Joining me are Jamie Bennett, Founder and Director of Operations, and Ryan Castle, Director of Research at The Cancer Playbook and Whole Health Oncology Institute.

In today's episode, we'll explore:

• How the Playbook empowers cancer patients with tools for symptom tracking, using and dosing Rick Simpson Oil, education, and support
• How it enhances physician decision-making through patient-reported outcomes using cannabis
• The value of this data in clinical research and cannabis drug discovery
• And how they're partnering with major research institutions to shape the future of cannabis and cancer care

https://cancerplaybook.org/

https://wholehealthoncologyinstitute.com/

The Mary Jane Society is produced and hosted by Pam Chmiel, a journalist, freelance writer, and marketing and PR specialist in the cannabis industry. Get in touch to discuss your business strategy or explore working together at pam@TheMaryJaneSociety.com.

LinkedIn Twitter Instagram

Please like the show to help us reach more listeners🙏🏻